NAT2 slow acetylation and bladder cancer in workers exposed to benzidine (Q23922349)

20 October 2023

Tania Carreón-Valencia

1

Tania Carreón

Tania

Carreón

1 reference

20 October 2023

3

Paul A. Schulte

Paul A

Schulte

1 reference

20 October 2023

6

Martha Waters

Martha

Waters

1 reference

20 October 2023

2

Avima M. Ruder

Avima M

Ruder

1 reference

20 October 2023

Richard B. Hayes

4

Richard B

Hayes

1 reference

20 October 2023

Delores J. Grant

7

Delores J

Grant

1 reference

20 October 2023

Robert Boissy

8

Robert

Boissy

1 reference

20 October 2023

Douglas A. Bell

9

Douglas A

Bell

1 reference

20 October 2023

Fred F. Kadlubar

10

Fred F

Kadlubar

1 reference

20 October 2023

George P. Hemstreet

11

George P 3rd

Hemstreet

1 reference

20 October 2023

Songnian Yin

12

Songnian

Yin

1 reference

20 October 2023

Grace K. LeMasters

13

Grace K

LeMasters

1 reference

International Journal of Cancer

20 October 2023

language of work or name

English

0 references

publication date

2005

0 references

published in

0 references

volume

118

0 references

issue

1

0 references

page(s)

161-168

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

2 references

2 February 2024

inferred from email address

cites work

Risk factors for bladder cancer in a cohort exposed to aromatic amines

1 reference

7 January 2021

A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma

1 reference

7 January 2021

Determination of human NAT2 acetylator genotype by restriction fragment-length polymorphism and allele-specific amplification

1 reference

7 January 2021

Mechanism of 3-(glutathion-S-yl)-benzidine formation

1 reference

7 January 2021

Dependence of papanicolaou gradings of exfoliated urothelial cells upon GSTM1 and GSTT1 polymorphism in benzidine-exposed workers of the Shanghai dye industry

1 reference

7 January 2021

Tobacco use and occupational exposure to carcinogens, but not N-acetyltransferase 2 genotypes are major risk factors for bladder cancer in the Japanese

1 reference

7 January 2021

N-acetyltransferase polymorphism. Comparison of phenotype and genotype in humans

1 reference

7 January 2021

Meta-analysis in clinical trials

1 reference

7 January 2021

An international study of smoking and bladder cancer.

1 reference

7 January 2021

Acetylator phenotype in human bladder cancer.

1 reference

7 January 2021

Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer

1 reference

7 January 2021

Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect.

1 reference

7 January 2021

The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences

1 reference

7 January 2021

Cigar, pipe, and cigarette smoking and bladder cancer risk in European men.

1 reference

7 January 2021

A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands).

1 reference

7 January 2021

Aromatic amines and cancer

1 reference

7 January 2021

Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer

1 reference

7 January 2021

Re-evaluation of the latent period of bladder cancer in dyestuff-plant workers in Japan

1 reference

7 January 2021

The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers

1 reference

7 January 2021

Benzidine Exposure as a Cause of Bladder Tumors

1 reference

7 January 2021

N-acetylbenzidine-N'-glucuronidation by human, dog and rat liver

1 reference

7 January 2021

N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.

1 reference

7 January 2021

N-acetylbenzidine and N,N'-diacetylbenzidine formation by rat and human liver slices exposed to benzidine.

1 reference

7 January 2021

A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people

1 reference

7 January 2021

Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.

1 reference

7 January 2021

Biomarker risk assessment and bladder cancer detection in a cohort exposed to benzidine

1 reference

7 January 2021

Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites.

1 reference

7 January 2021

Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males

1 reference

7 January 2021

The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the Black Foot Disease endemic area population

1 reference

7 January 2021

NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population

1 reference

7 January 2021

Acetylation phenotypes and bladder cancer

1 reference

7 January 2021

N-acetyltransferase activity in the urine in Japanese subjects: comparison in healthy persons and bladder cancer patients

1 reference

7 January 2021

Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic amines

1 reference

7 January 2021

N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark

1 reference

7 January 2021

CYP1A2 activity as a risk factor for bladder cancer

1 reference

7 January 2021

Identifiers

DOI

10.1002/IJC.21308

1 reference

Consolidated OpenCitations Corpus – April 2017

release_pwjjmjneybfazjw55jyakgudhi

Fatcat ID

0 references

NIOSHTIC-2 ID

20028941

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017